BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688002 Raytron Technology
- 57.70
- -1.22-2.07%
Market Closed May 15 15:00 CST
26.25BMarket Cap44.76P/E (TTM)
59.08High57.50Low24.79KlotVolume58.72Open58.92Pre Close144.01MTurnover0.55%Turnover Ratio46.12P/E (Static)454.92MShares67.8952wk High4.86P/B26.25BFloat Cap23.5152wk Low70.70Limit Up454.92MShs Float129.09Historical High47.14Limit Down2.68%Amplitude23.51Historical Low0.18Dividend TTM58.09Avg Price13.15KlotAsk0.30%Div YieldTTM100Lot Size10.11KlotBid
Raytron Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 12.88%1.14B | 21.28%4.32B | 18.31%3.15B | 13.32%2.02B | 27.47%1.01B | 34.50%3.56B | 55.70%2.66B | 64.16%1.78B | 77.45%789.9M | 48.62%2.65B |
| Operating revenue | 12.88%1.14B | 21.28%4.32B | 18.31%3.15B | 13.32%2.02B | 27.47%1.01B | 34.50%3.56B | 55.70%2.66B | 64.16%1.78B | 77.45%789.9M | 48.62%2.65B |
| Total operating cost | 13.48%1.01B | 18.67%3.72B | 16.23%2.62B | 16.87%1.74B | 25.21%891.44M | 34.19%3.14B | 48.48%2.25B | 54.18%1.49B | 62.99%711.98M | 71.39%2.34B |
| Operating cost | 12.38%614.27M | 18.08%2.15B | 15.14%1.54B | 14.06%1.02B | 29.38%546.58M | 28.63%1.82B | 47.76%1.34B | 56.08%895.78M | 80.11%422.45M | 90.58%1.41B |
| Operating tax surcharges | 67.22%11.65M | 103.26%65.16M | 97.47%47.18M | 130.03%35.94M | -32.01%6.97M | 184.20%32.06M | 221.35%23.89M | 218.74%15.63M | 511.72%10.24M | 15.84%11.28M |
| Operating expense | 17.58%58.26M | 24.29%217.82M | 25.13%151.32M | 23.30%112.28M | 28.65%49.55M | 15.57%175.26M | 23.96%120.93M | 40.91%91.06M | 5.68%38.51M | 93.44%151.65M |
| Administration expense | -12.11%84.73M | -1.75%383.88M | -4.03%268.49M | 7.35%183.74M | 5.65%96.4M | 68.17%390.71M | 84.80%279.76M | 81.04%171.16M | 113.06%91.25M | 96.06%232.33M |
| Financial expense | -21.46%9.42M | 28.52%46.51M | 26.17%35.51M | 33.50%19.85M | -25.36%11.99M | 535.28%36.19M | 305.30%28.15M | 432.77%14.87M | 471.21%16.07M | -212.33%-8.31M |
| -Interest expense (Financial expense) | -6.36%16.23M | -6.08%69.03M | -5.80%52.74M | -6.49%35.14M | 8.44%17.33M | 350.71%73.5M | 364.06%55.98M | 366.44%37.58M | 436.70%15.98M | 908.45%16.31M |
| -Interest Income (Financial expense) | 59.22%-1.63M | 48.20%-13.56M | 54.50%-9.89M | 54.22%-7.16M | 33.71%-4.01M | -151.61%-26.19M | -194.09%-21.74M | -209.81%-15.64M | -287.91%-6.05M | -15.40%-10.41M |
| Research and development | 29.64%233.3M | 25.96%860.73M | 24.52%575.3M | 21.92%370.83M | 34.83%179.95M | 27.39%683.33M | 25.19%462.01M | 29.65%304.16M | 12.60%133.47M | 28.40%536.41M |
| Credit Impairment Loss | 105.79%941.86K | -311.85%-170.19M | -281.78%-166.58M | -303.01%-132.57M | -140.54%-16.27M | -236.63%-41.32M | -470.68%-43.63M | -652.29%-32.9M | -629.20%-6.76M | 24.02%-12.28M |
| Asset Impairment Loss | -186.69%-16.99M | -72.15%-136.72M | -83.96%-69.75M | 49.45%-18.2M | -1,168.86%-5.93M | -1.85%-79.42M | -12.66%-37.91M | -227.47%-36.01M | 112.46%554.39K | -338.64%-77.97M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
| Other net revenue | ||||||||||
| Fair value change income | 162.05%342.42K | 215.26%40.53K | -82.52%195.11K | -78.09%95.11K | -89.81%130.67K | -100.15%-35.17K | 334.15%1.12M | 41.27%434.2K | 2,033.87%1.28M | --23.55M |
| Invest income | -3.54%6.52M | 3.48%32.84M | 6.93%21.26M | 30.25%15.98M | 93.35%6.76M | 232.16%31.73M | 109.77%19.88M | 144.26%12.27M | 2.38%3.5M | -41.56%9.55M |
| -Including: Investment income associates | 586.34%1.03M | -1.25%8.09M | -55.26%1.99M | -29.57%2.17M | -84.43%150.01K | 20.87%8.19M | -40.09%4.44M | -21.48%3.08M | -55.27%963.44K | 4.81%6.77M |
| Asset deal income | 126.48%6.9K | -28.32%-102.13K | 105.78%4.6K | 108.83%7.03K | ---26.04K | -470.28%-79.59K | -470.28%-79.59K | ---79.59K | ---- | -62.33%21.49K |
| Other revenue | 28.44%12.04M | 56.75%121.49M | 211.70%90.62M | 207.77%63.21M | 126.25%9.38M | 47.65%77.51M | 15.54%29.07M | 53.31%20.54M | -22.05%4.14M | 3.58%52.49M |
| Adjusted Items effecting operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
| Operating profit | 16.70%127.76M | 7.48%442.1M | 7.77%408.38M | -19.50%205.83M | 35.78%109.48M | 35.11%411.34M | 102.68%378.93M | 109.53%255.68M | 479.31%80.63M | -32.35%304.45M |
| Add:Non operating Income | 50.73%390.08K | -6.65%2.06M | -43.03%614.3K | -46.79%421.6K | -53.26%258.79K | 28.29%2.2M | -24.17%1.08M | -36.64%792.3K | 462.09%553.68K | -52.76%1.72M |
| Less:Non operating expense | -29.51%371.43K | 12.31%16.14M | 652.27%10.97M | 670.03%8.85M | 1,107.99%526.92K | 717.70%14.37M | 29.64%1.46M | 202.21%1.15M | -84.04%43.62K | -67.48%1.76M |
| Total profit | 17.01%127.78M | 7.23%428.02M | 5.15%398.02M | -22.69%197.39M | 34.59%109.21M | 31.13%399.17M | 102.15%378.55M | 107.76%255.32M | 490.39%81.14M | -32.09%304.41M |
| Less:Income tax cost | 95.14%14.37M | 38.40%-14.18M | -41.89%12.1M | 65.75%24.76M | 25.39%7.36M | -228.68%-23.02M | 255.11%20.82M | 28.54%14.94M | 795.13%5.87M | 267.06%17.89M |
| Net profit | 11.36%113.41M | 4.74%442.2M | 7.88%385.93M | -28.18%172.64M | 35.31%101.85M | 47.35%422.19M | 97.21%357.73M | 116.03%240.38M | 415.95%75.27M | -37.57%286.52M |
| Net profit from continuing operation | 11.36%113.41M | 4.74%442.2M | 7.88%385.93M | -28.18%172.64M | 35.31%101.85M | 47.35%422.19M | 97.21%357.73M | 116.03%240.38M | 415.95%75.27M | -37.57%286.52M |
| Less:Minority Profit | -21.28%-32.4M | -72.28%-126.76M | -234.21%-97.47M | -200.40%-51.7M | -322.27%-26.72M | -174.06%-73.58M | -2,812.96%-29.16M | -1,335.52%-17.21M | -2,164.40%-6.33M | -1,111.18%-26.85M |
| Net profit of parent company owners | 13.42%145.82M | 14.76%568.96M | 24.94%483.4M | -12.91%224.34M | 57.56%128.57M | 58.21%495.77M | 112.12%386.89M | 129.03%257.59M | 471.33%81.6M | -32.05%313.36M |
| Earning per share | ||||||||||
| Basic earning per share | 11.52%0.3205 | 15.32%1.28 | 25.29%1.09 | -13.79%0.5 | 57.22%0.2874 | 58.57%1.11 | 112.61%0.87 | 129.52%0.58 | 469.47%0.1828 | -32.46%0.7 |
| Diluted earning per share | 12.41%0.3161 | 16.67%1.26 | 26.19%1.06 | -12.50%0.49 | 57.71%0.2812 | 54.29%1.08 | 106.39%0.84 | 122.84%0.56 | 458.93%0.1783 | -31.90%0.7 |
| Other composite income | -13,734.76%-40.2K | -11,104.45%-21.2M | 993.72%304.24K | -654.31%-229.58K | 98.27%-290.58 | -100.79%-189.17K | -60.23%27.82K | 41.42K | -16.81K | -1.27%23.94M |
| Other composite income of parent company owners | -13,734.76%-40.2K | -11,104.45%-21.2M | 993.72%304.24K | -654.31%-229.58K | 98.27%-290.58 | -100.79%-189.17K | -60.23%27.82K | --41.42K | ---16.81K | -1.27%23.94M |
| Total composite income | 11.32%113.37M | -0.24%421.01M | 7.96%386.23M | -28.29%172.41M | 35.34%101.85M | 35.93%422M | 97.15%357.76M | 116.07%240.42M | 415.84%75.25M | -35.75%310.46M |
| Total composite income of parent company owners | 13.39%145.78M | 10.53%547.76M | 25.01%483.7M | -13.01%224.11M | 57.60%128.57M | 46.92%495.58M | 112.05%386.92M | 129.07%257.63M | 471.21%81.58M | -30.51%337.3M |
| Total composite income of minority owners | -21.28%-32.4M | -72.28%-126.76M | -234.21%-97.47M | -200.40%-51.7M | -322.27%-26.72M | -174.06%-73.58M | -2,812.96%-29.16M | -1,335.52%-17.21M | -2,164.40%-6.33M | -1,111.18%-26.85M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.